During the projected period of 2021-2027, the “Metabotropic Glutamate Receptor 2 Market” research describes in-depth the demand and consumption of numerous products/services connected to market growth dynamics. In terms of quantity, a complete market assessment of the numerous opportunities in the market segment is made. The Metabotropic Glutamate Receptor 2 market is covered several areas, including constraints, problems, and opportunities, as well as geographical considerations. Customers will benefit from this study because it provides historical and statistically significant data, making it both helpful and instructional.
In accordance with the Metabotropic Glutamate Receptor 2 market is set to grow at a CAGR of 5.6% over the forecast period (2021-2027).
Get a Sample PDF Report Here:
Metabotropic Glutamate Receptor 2 (mGluR2 or GRM2 or GPRC1B or MGLUR2) Metabotropic glutamate receptor 2 is a protein encoded by the GRM2 gene. It is a receptor for glutamate. Ligand binding causes a conformation change that triggers signalling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors, such as adenylate cyclase. Signalling inhibits adenylate cyclase activity. May mediate suppression of neurotransmission or may be involved in synaptogenesis or synaptic stabilization. The molecules developed by Companies in Phase II and Preclinical stages are 1 and 7 respectively. Similarly, the Universities portfolio in the Discovery stages comprises 1 molecule, respectively.
Top Key players operating in the global Metabotropic Glutamate Receptor 2 market is:
Addex Therapeutics Ltd, Bristol-Myers Squibb Company, Denovo Biopharma LLC, Domain Therapeutics SA, Eli Lilly and Company, Johnson & Johnson, Merck & Co Inc
- Johnson & Johnson has made Momenta (Aug 2020), Taris Biomedical (Dec 2019), Verb Surgical (Dec 2019) acquisitions and 15 investments. The company has spent over $ 86.60B on the acquisitions. Johnson & Johnson has invested in multiple sectors such as Orthopedics, Infectious Diseases, Life Sciences Platforms and Tools and more.
- Merck has acquired 29 companies, including 16 in the last 5 years. A total of 8 acquisitions came from private equity firms. It has also divested 7 assets. Merck’s largest acquisition to date was in 2009 when it acquired Schering-Plough for $41.1B. Its largest disclosed sale occurred in 2009 when it sold Merial to Sanofi SA for $4.0B. Merck has acquired in 10 different US states, and 7 countries. The Company’s most targeted sectors include life science (90%) and information technology (4%).
Major Metabotropic Glutamate Receptor 2 Market Types covered are:
Major Metabotropic Glutamate Receptor 2 Market Applications covered are:
- Anxiety Disorders
- Chronic Pain
Access Full Report, here:
Regional Analysis of Global Metabotropic Glutamate Receptor 2 market:
The Metabotropic Glutamate Receptor 2 Market research gives an in-depth analysis of market growth and other factors in key nations (regions), including:
- North America (the United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of the Middle East & Africa)
Buy Report Here:
Table of Contents: Metabotropic Glutamate Receptor 2 Market
– Chapter 1: outline of Metabotropic Glutamate Receptor 2 marketplace
– Chapter 2: worldwide market reputation and forecast through areas
– Chapter 3: worldwide marketplace popularity and forecast by using types
– Chapter 4: worldwide marketplace repute and forecast by using Downstream enterprise
– Chapter 5: marketplace riding issue evaluation
– Chapter 6: market opposition reputation by major producers
– Chapter 7: essential producers Presentation and market data
– Chapter 8: Upstream and Downstream marketplace investigation
– Chapter 9: Fetched and net part investigation
– Chapter 10: advertising reputation research
– Chapter 11: marketplace file end
– Chapter 12: research technique and Reference
Impact of COVID-19 on the Metabotropic Glutamate Receptor 2 Market:
The upward push of COVID-19 has moderated showcase improvement; anyhow, the market is constantly selecting up-tempo due to growing lockdowns. The sudden increment in CAGR is thanks to the request and extension of this marketplace, which is functionality to return to pre-pandemic ranges once the large, is gone.
Market intelligence data may be a global front-runner within the research industry, offering contextual and data-driven research services to customers. Customers are supported in creating business plans and attaining long-term success in their respective marketplaces by the organization. The industry provides consulting services, Market Intelligence Data research studies, and customised research reports.
Irfan Tamboli (Head of Sales) – MARKET INTELLIGENCE DATA
Phone: +1 (704) 266-3234
Mail to: email@example.com